Discontinuation report BUSULFEX
Report ID | 120940 |
Drug Identification Number | 02240602 |
Brand name | BUSULFEX |
Common or Proper name | busulfex |
Company Name | OTSUKA PHARMACEUTICAL CO LTD |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUSULFAN |
Strength(s) | 60MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 6mg/mL, 10 mL vial |
ATC code | L01AB |
ATC description | ALKYLATINGAGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-09-01 |
Actual discontinuation date | 2020-09-01 |
Remaining supply date | 2020-10-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-09-02 | English | Compare |
v5 | 2020-07-23 | French | Compare |
v4 | 2020-07-23 | English | Compare |
v3 | 2020-07-23 | French | Compare |
v2 | 2020-07-23 | English | Compare |
v1 | 2020-07-23 | English | Compare |
Showing 1 to 6 of 6